21,894 Shares in Envista Holdings Corporation $NVST Acquired by Callan Family Office LLC

Callan Family Office LLC purchased a new stake in Envista Holdings Corporation (NYSE:NVST) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 21,894 shares of the company’s stock, valued at approximately $577,000.

Several other hedge funds have also added to or reduced their stakes in NVST. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Envista in the second quarter valued at about $25,000. Caitong International Asset Management Co. Ltd lifted its stake in shares of Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after buying an additional 1,504 shares during the last quarter. Allworth Financial LP boosted its holdings in shares of Envista by 75.4% during the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock worth $39,000 after buying an additional 776 shares during the period. UMB Bank n.a. boosted its holdings in shares of Envista by 46.1% during the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after buying an additional 636 shares during the period. Finally, IFP Advisors Inc grew its stake in Envista by 102.9% in the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after buying an additional 1,071 shares during the last quarter.

Insider Transactions at Envista

In other Envista news, SVP Mischa Reis sold 8,000 shares of the stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $27.50, for a total transaction of $220,000.00. Following the sale, the senior vice president directly owned 27,321 shares in the company, valued at $751,327.50. This represents a 22.65% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.99% of the stock is owned by insiders.

Envista Stock Performance

NYSE:NVST opened at $27.52 on Wednesday. The stock has a fifty day moving average price of $27.00 and a 200-day moving average price of $26.36. The company has a market cap of $4.42 billion, a price-to-earnings ratio of 47.44, a PEG ratio of 1.30 and a beta of 0.86. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.07 and a current ratio of 2.43. Envista Holdings Corporation has a fifty-two week low of $18.77 and a fifty-two week high of $30.42.

Envista (NYSE:NVST) last released its earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.07. Envista had a return on equity of 7.88% and a net margin of 3.33%.The company had revenue of $730.50 million for the quarter, compared to analyst estimates of $716.11 million. During the same period in the prior year, the firm posted $0.26 EPS. Envista’s quarterly revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, equities analysts anticipate that Envista Holdings Corporation will post 1.53 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Barclays lowered their price target on shares of Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday, June 11th. Zacks Research upgraded Envista from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. Evercore reaffirmed an “outperform” rating and issued a $33.00 target price on shares of Envista in a research report on Thursday, May 7th. Robert W. Baird set a $34.00 target price on Envista in a research note on Thursday, August 6th. Finally, JPMorgan Chase & Co. lifted their price target on Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $29.31.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.